Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, August 16, 2022.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN)
Long-Term Uptrend (+90) - DAWN is in a strong uptrend that is likely to continue. While DAWN is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid DAWN?
MarketClub looks at technical strength and momentum to determine if the timing is right for DAWN.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for DAWN
The long-term trend has been UP since Jun 13th, 2022 at 14.20
The intermediate-term trend has been UP since Aug 4th, 2022 at 20.02
The short-term trend has been UP since Aug 3rd, 2022 at 17.56
Smart Scan Analysis for DAWN
Based on our trend formula, DAWN is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 25.010 | 25.335 | 24.070 | 24.240 | -0.760 |
| Prev. Close | Volume | Bid | Ask | Time |
| 25.000 | 438430 | 2022-08-16 14:39:08 |
| 52wk High | 28.699 | 52wk High Date | 2021-09-07 |
| 52wk Low | 5.44 | 52wk Low Date | 2022-05-27 |
| Average Volume | 488,363 | Shares Outstanding | 73,461 |
| Assets | 404,047,000M | Liabilities | 13,416,000M |